Cannabis Industry Celebrates Green Wednesday Amid Legislative and Scientific Developments
The cannabis industry celebrates Green Wednesday with a focus on legislative updates in Ohio, significant hemp industry actions, and groundbreaking research on cannabis terpenes
Key Points
- 1Green Wednesday is the cannabis industry's biggest sales day, akin to Black Friday
- 2Ohio's Senate Bill 56 introduces updates to cannabis legalization, including expungement pathways
- 3US Hemp Roundtable calls for a moratorium on hemp ban following Agriculture Appropriations Bill
- 4Healer webinar highlights cannabis research for various medical conditions
- 5Israeli study reveals terpenes' role in activating cannabinoid receptors, suggesting new product design opportunities
As the cannabis industry gears up for its version of Black Friday, known as Green Wednesday, stakeholders are reflecting on a week filled with significant developments. Green Wednesday, the day before Thanksgiving, is traditionally the biggest sales day of the year for cannabis retailers, rivaling the post-Thanksgiving shopping frenzy seen in other industries. To mark this occasion, Cannabis Science and Technology has curated a collection of articles and content focusing on various aspects of the cannabis industry, from product manufacturing to scientific research
In Ohio, legislative progress was made with Senate Bill 56, which has now passed through both the state House and Senate and is awaiting final approval. This bill introduces several key changes to Ohio's voter-approved cannabis legalization framework. Among the updates, it restricts certain hemp-derived products to state-licensed dispensaries, provides a pathway for expungement of prior cannabis convictions, and allows adults to legally consume cannabis within their private property. Additionally, it proposes that a portion of cannabis tax revenues be directed to municipalities licensing cannabis retailers
The US Hemp Roundtable issued a press release on November 24, 2025, outlining crucial action points following the passage of the FY26 Agriculture Appropriations Bill. The organization emphasized the need for a one-year moratorium on the ban's effective date, citing strong public opposition and increased congressional support for regulation over prohibition. This extension would provide the necessary time for thorough examination and responsible resolution of hemp-related issues, according to the Roundtable
Meanwhile, the November session of the Healer webinar series, led by Dr. Dustin Sulak, delved into recent studies on cannabis treatments for conditions such as diabetic neuropathy and chronic back pain. The webinar also explored the potential of cannabinoids in addressing Alzheimer's disease symptoms, highlighting the growing body of research supporting cannabis' therapeutic applications. This educational initiative underscores the importance of continuous learning and research in the evolving cannabis landscape
In scientific research, a noteworthy study from Israel has unveiled new insights into the role of cannabis terpenes in activating endogenous cannabinoid receptors. Published in Biochemical Pharmacology, the study found that terpenes such as α-pinene, limonene, and myrcene act as partial agonists at CB1R and CB2R receptors. These findings suggest a pharmacological basis for incorporating specific terpenes into product design focused on the endocannabinoid system (ECS), potentially enhancing the therapeutic efficacy of cannabis products